nandrolone phenylpropionate profile

The risk of increase of the ¬†interval is increased by concomitant treatment with drugs prolong the ¬†interval or inhibit the metabolism of sertindole. Using Serdolekta concurrently with such drugs is prohibited. Sertindole is metabolized via the cytochrome nandrolone phenylpropionate profile. Sertindole concentration in plasma increased by simultaneous reception with drugs that inhibit cytochrome. It may require the appointment of a lower maintenance dose, as well as conducting an ¬†examination before and after the change in the dose of these drugs. In turn, sertindole and its main metabolites have a weak…

Read More